Literature DB >> 22441677

MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.

Magdalena R Golachowska1, Carin M L van Dael, Hilda Keuning, Arend Karrenbeld, Dick Hoekstra, Carolien F M Gijsbers, Marc A Benninga, Edmond H H M Rings, Sven C D van Ijzendoorn.   

Abstract

BACKGROUND AND
OBJECTIVE: : Microvillus inclusion disease (MVID) is a rare congenital enteropathy associated with brush border atrophy and reduced expression of enzymes at the enterocytes' apical surface. MVID is associated with mutations in the MYO5B gene, which is expressed in all epithelial tissues. Whether organs other than the intestine are affected in MVID is unclear. We report 2 patients with MVID that developed renal Fanconi syndrome while receiving total parenteral nutrition. Renal Fanconi syndrome has been correlated to apical plasma membrane defects in kidney proximal tubular epithelial cells. The aim of the present study was to determine whether MYO5B mutations in these patients correlate with similar apical plasma membrane defects in renal tubular epithelial cells as observed in the intestine.
METHODS: : Biopsies from kidney, duodenum, ileum, jejunum, and colon of 2 patients with MVID carrying MYO5B mutations and of age-matched controls were fixed in paraffin and analyzed with immunohistochemistry and transmission electron microscopy.
RESULTS: : Structural defects of the brush border and apical recycling endosome organization are observed in enterocytes of all of the segments of the small intestine and colon. MYO5B mutations in patients with MVID with renal Fanconi syndrome do not correlate with aberrant apical plasma membrane morphology or altered apical recycling endosome organization in renal tubular epithelial cells.
CONCLUSIONS: : MYO5B mutations have divergent effects on the apical membrane system in kidney and intestinal epithelial cells. Epithelial defects presented in MVID are therefore likely triggered by intestine-specific factors, the identification of which may provide new targets and open avenues for the development of alternative therapeutic strategies to combat this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441677     DOI: 10.1097/MPG.0b013e3182353773

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  14 in total

1.  Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.

Authors:  Dmitri Kravtsov; Anastasia Mashukova; Radia Forteza; Maria M Rodriguez; Nadia A Ameen; Pedro J Salas
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

2.  Extraintestinal manifestations in an infant with microvillus inclusion disease: complications or features of the disease?

Authors:  Tania Siahanidou; Eirini Koutsounaki; Anna-Venetia Skiathitou; Kalliopi Stefanaki; Evangelos Marinos; Ioanna Panajiotou; Giorgos Chouliaras
Journal:  Eur J Pediatr       Date:  2013-01-25       Impact factor: 3.183

3.  Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.

Authors:  Byron C Knowles; Joseph T Roland; Moorthy Krishnan; Matthew J Tyska; Lynne A Lapierre; Paul S Dickman; James R Goldenring; Mitchell D Shub
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

4.  Identification of intestinal ion transport defects in microvillus inclusion disease.

Authors:  Dmitri V Kravtsov; Md Kaimul Ahsan; Vandana Kumari; Sven C D van Ijzendoorn; Miguel Reyes-Mugica; Anoop Kumar; Tarunmeet Gujral; Pradeep K Dudeja; Nadia A Ameen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-26       Impact factor: 4.052

Review 5.  MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update.

Authors:  Herschel S Dhekne; Olena Pylypenko; Arend W Overeem; Malik Zibouche; Rosaria J Ferreira; K Joeri van der Velde; Edmond H H M Rings; Carsten Posovszky; Peter van der Sluijs; Morris A Swertz; Anne Houdusse; Sven C D van IJzendoorn
Journal:  Hum Mutat       Date:  2018-01-17       Impact factor: 4.878

6.  Loss of myosin Vb promotes apical bulk endocytosis in neonatal enterocytes.

Authors:  Amy C Engevik; Izumi Kaji; Meagan M Postema; James J Faust; Anne R Meyer; Janice A Williams; Gillian N Fitz; Matthew J Tyska; Jean M Wilson; James R Goldenring
Journal:  J Cell Biol       Date:  2019-09-27       Impact factor: 10.539

7.  Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells.

Authors:  Swagatika Sahoo; Ines Thiele
Journal:  Hum Mol Genet       Date:  2013-03-13       Impact factor: 6.150

Review 8.  The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders.

Authors:  Arend W Overeem; Carsten Posovszky; Edmond H M M Rings; Ben N G Giepmans; Sven C D van IJzendoorn
Journal:  Dis Model Mech       Date:  2016-01       Impact factor: 5.758

9.  Towards understanding microvillus inclusion disease.

Authors:  Georg F Vogel; Michael W Hess; Kristian Pfaller; Lukas A Huber; Andreas R Janecke; Thomas Müller
Journal:  Mol Cell Pediatr       Date:  2016-01-29

Review 10.  Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease.

Authors:  Dulari Jayawardena; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  F1000Res       Date:  2019-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.